618O A phase I study of TRS005: An anti-CD20-MMAE antibody-drug conjugate, in relapsed or refractory b cell non-Hodgkin lymphoma
Antibody-drug conjugate
Conjugate
Refractory (planetary science)
DOI:
10.1016/j.annonc.2022.07.744
Publication Date:
2022-09-13T18:46:15Z
AUTHORS (10)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....